X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31) 31
index medicus (30) 30
oncology (22) 22
male (19) 19
female (17) 17
adult (16) 16
aged (16) 16
chemotherapy (16) 16
middle aged (15) 15
head and neck cancer (14) 14
cancer (13) 13
radiotherapy (12) 12
care and treatment (11) 11
head (11) 11
metastasis (10) 10
carcinoma (8) 8
hematology, oncology and palliative medicine (8) 8
aged, 80 and over (7) 7
dentistry, oral surgery & medicine (7) 7
expression (7) 7
otolaryngology (7) 7
prognosis (7) 7
recurrent (7) 7
squamous-cell carcinoma (7) 7
surgery (7) 7
analysis (6) 6
neoplasm staging (6) 6
otorhinolaryngology (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
cancer patients (5) 5
carcinoma, squamous cell - drug therapy (5) 5
development and progression (5) 5
head and neck neoplasms - drug therapy (5) 5
immunology (5) 5
nasopharyngeal carcinoma (5) 5
neck-cancer (5) 5
radiation-therapy (5) 5
survival (5) 5
adenoid cystic carcinoma (4) 4
carboplatin - administration & dosage (4) 4
cell biology (4) 4
cetuximab (4) 4
combined modality therapy (4) 4
duct carcinoma (4) 4
head & neck cancer (4) 4
head and neck neoplasms - radiotherapy (4) 4
head and neck neoplasms - therapy (4) 4
immunotherapy (4) 4
intensity-modulated radiotherapy (4) 4
magnetic resonance imaging (4) 4
medical prognosis (4) 4
metastases (4) 4
monocytes - immunology (4) 4
oral mucositis (4) 4
patient outcomes (4) 4
patients (4) 4
phase-ii (4) 4
research (4) 4
retrospective studies (4) 4
salivary gland cancer (4) 4
salivary gland neoplasms - drug therapy (4) 4
settore med/06 - oncologia medica (4) 4
survival analysis (4) 4
treatment outcome (4) 4
tumors (4) 4
androgen deprivation therapy (3) 3
antineoplastic agents - adverse effects (3) 3
apoptosis (3) 3
biochemistry & molecular biology (3) 3
cd40 ligand - immunology (3) 3
cetuximab - administration & dosage (3) 3
clinical trials (3) 3
dendritic cells (3) 3
down-regulation (3) 3
drug therapy (3) 3
flow cytometry (3) 3
head and neck neoplasms - complications (3) 3
health aspects (3) 3
methods (3) 3
nasopharyngeal neoplasms - mortality (3) 3
neck (3) 3
neoplasm recurrence, local - drug therapy (3) 3
neoplasms (3) 3
prospective studies (3) 3
radiation (3) 3
radiation therapy (3) 3
recurrence (3) 3
research paper (3) 3
review (3) 3
squamous cell carcinoma of head and neck (3) 3
stomatitis (3) 3
stomatitis - etiology (3) 3
t cells (3) 3
toxicity (3) 3
young adult (3) 3
adolescent (2) 2
analgesics, opioid - administration & dosage (2) 2
analgesics, opioid - therapeutic use (2) 2
androgen receptor (2) 2
antibodies, monoclonal - administration & dosage (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Head & Neck, ISSN 1043-3074, 06/2019, Volume 41, Issue 6, pp. 1895 - 1902
Background In clinical trials of recurrent and metastatic head and neck carcinoma, Argiris et al have identified prognostic factors for overall survival (OS)... 
recurrence | head and neck cancer | classification | prognosis | squamous cell carcinoma | SURVIVAL | SURGERY | HUMAN-PAPILLOMAVIRUS | FLUOROURACIL | CHEMOTHERAPY | CISPLATIN | OTORHINOLARYNGOLOGY | SALVAGE SURGERY | Squamous cell carcinoma | Prognosis | Metastasis | Papillomavirus infections | Analysis | Medical prognosis | Classification | Clinical trials | Head and neck cancer | Radiation therapy | Metastases
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 5, pp. 959 - 966
Purpose We assessed the presence of salivary cytokines, their modulation during chemoradiation therapy (CTRT), and their association with oral mucositis... 
Radiology | Hematology, Oncology and Palliative Medicine | PRO-INFLAMMATORY CYTOKINES | RECEIVING RADIOTHERAPY | PROTEIN | ONCOLOGY | PATHOBIOLOGY | DRUGS | SQUAMOUS-CELL CARCINOMA | CHEMORADIOTHERAPY | INTERLEUKIN-6 | EXPRESSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SEVERITY | Oropharyngeal Neoplasms - therapy | Interleukin-6 - analysis | Chemoradiotherapy - adverse effects | Prospective Studies | Area Under Curve | Cytokines - analysis | Humans | Saliva - chemistry | Cisplatin - administration & dosage | Laryngeal Neoplasms - therapy | Fluorouracil - administration & dosage | Time Factors | Dose Fractionation | Severity of Illness Index | Interleukin-1beta - analysis | Nasopharyngeal Neoplasms - therapy | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - therapy | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Stomatitis - etiology | Mouth Neoplasms - therapy | Stomatitis - metabolism | Tumor Necrosis Factor-alpha - analysis | Hypopharyngeal Neoplasms - therapy | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma - therapy | Cetuximab - administration & dosage | Stomatitis | Care and treatment | Cancer patients | Chemotherapy | Cytokines | Immunotherapy | Radiation | Head and neck cancer | Radiotherapy | Epidemiology | Cancer | Index Medicus | HEAD | PATIENTS | LYMPHOKINES | NEOPLASMS | RADIATION HAZARDS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY | CHEMOTHERAPY
Journal Article
CYTOKINE, ISSN 1043-4666, 03/2009, Volume 45, Issue 3, pp. 190 - 197
CD40 ligand (CD40L) stimulation induces proinflammatory and immunomodulatory activity in monocytes. Here, we report on the effects of the steroid hormone 1... 
CD40L | RHEUMATOID-ARTHRITIS | ANTIGEN EXPRESSION | SOLUBLE CD40 LIGAND | SYSTEMIC-LUPUS-ERYTHEMATOSUS | HUMAN DENDRITIC CELLS | Monocyte | T cell | VITAMIN-D INTAKE | BIOCHEMISTRY & MOLECULAR BIOLOGY | Cytokine | CD4(+) T-CELLS | IMMUNOLOGY | CELL BIOLOGY | MULTIPLE-SCLEROSIS | 1 alpha,25-Dihydroxyvitamin D-3 | 1,25-DIHYDROXYVITAMIN D-3 | PERIPHERAL-BLOOD MONOCYTES
Journal Article
Targeted Oncology, ISSN 1776-2596, 4/2018, Volume 13, Issue 2, pp. 253 - 256
Retreatment with vismodegib in advanced basal cell carcinoma (BCC) patients who previously discontinued the drug due to disease progression (PD) has not been... 
Biomedicine, general | Medicine & Public Health | Oncology | TRIAL | HEDGEHOG PATHWAY | EFFICACY | ONCOLOGY | SAFETY | ACQUIRED-RESISTANCE | RECHALLENGE | Medicine, Experimental | Medical research | Development and progression | Basal cell carcinoma | Metastasis | Chemotherapy | Targeted cancer therapy | Clinical outcomes | Skin cancer
Journal Article
Journal Article
Oncology, ISSN 0030-2414, 07/2019, Volume 97, Issue 2, pp. 112 - 118
Background: Recurrent or metastatic (R/M) skin squamous cell carcinoma (sSCC) not amenable of surgery or irradiation may benefit from systemic therapies.... 
Clinical Translational Research | HEAD | ACTIVATION | NSCLC | IMMUNE ESCAPE | PHASE-II | Epidermal growth factor receptor | EGFR | LIGAND 1 EXPRESSION | CETUXIMAB | Skin squamous cell carcinoma | THERAPY | ONCOLOGY | Outcome | PD-L1 | Anti-epidermal growth factor receptor treatment
Journal Article